(MedPage Today) — The FDA approved tradipitant (Nereus), an oral neurokinin-1 (NK-1) receptor antagonist, to prevent vomiting induced by motion in adults, Vanda Pharmaceuticals announced Tuesday.
The approval marks the first new drug treatment…
Source link : https://www.medpagetoday.com/neurology/generalneurology/119230
Author :
Publish date : 2025-12-31 14:16:00
Copyright for syndicated content belongs to the linked Source.
